![]() |
市場調查報告書
商品編碼
1610887
人工電子耳:市場洞察·競爭環境·市場預測 (~2030年)Cochlear Implants - Market Insights, Competitive Landscape, and Market Forecast - 2030 |
人工耳蝸市場規模預計將從 2023 年的 13.8 億美元成長到 2030 年的 24.3 億美元,預測期內複合年增長率為 9.92%。
人工耳蝸市場呈現顯著的市場成長,主要是由於聽力損失的盛行率不斷增加,並繼續推動人工耳蝸的投資、人工耳蝸的普及以及支持性報銷政策等預計在預測期內將進一步推動。
人工耳蝸:市場動態
根據世界衛生組織 (WHO) 數據(2024 年),預計到 2050 年,大約有 25 億人會出現某種形式的聽力損失,全球至少有 7 億人需要聽力復健。此外,同一消息來源稱,由於不安全的聆聽習慣,超過 10 億年輕人面臨永久性和可預防的聽力損失的風險。
根據世界衛生組織數據(2024年),2021年非洲將有1.36億人遭受聽力損失,預計2050年將有3.37億人受到聽力問題的影響。同一消息人士也預測,2021年歐洲將有1.96億人遭受聽力損失,2050年將有2.36億人受到聽力問題的影響。
人工耳蝸對於解決嚴重聽力損失至關重要,並為個人帶來顯著益處。直接刺激聽覺神經可以改善聲音感知,改善溝通和生活品質。人工耳蝸可以幫助減少與未經治療的聽力損失相關的長期成本。人工耳蝸賦予個人力量,讓他們過著更積極和獨立的生活,並降低與聽力損失相關的整體社會和經濟成本。
有利的報銷政策和政府措施顯著改善了人工耳蝸植入的機會。世界各國都在實施類似措施。在歐盟,許多國家透過國家衛生系統補貼或全額支付人工耳蝸植入費用
政府機構和非營利組織也為使人工耳蝸植入更容易做出重大貢獻。人工耳蝸基金會等組織倡導提供資金和政策改變,以幫助需要人工耳蝸的患者。此類措施對於確保聽力技術的進步惠及最需要的人並改善聽力損失者的生活品質至關重要。
所有這些因素預計將在預測期內推動市場發展。
本報告調查了全球人工耳蝸市場,並提供了市場概況、市場影響因素和市場機會分析、法律和監管環境、市場規模趨勢和預測,以及各個細分市場、地區和主要國家的詳細信息。
Cochlear implants Market by Implantation (Unilateral Implantation and Bilateral Implantation), End-User (Adults and Paediatrics), and Geography (North America, Europe, Asia-Pacific, and Rest of the World) is expected to advance at a respectable CAGR forecast till 2030 owing to the increasing instances of hearing loss and rising product developmental activities across the world
The cochlear implants market was valued at USD 1.38 billion in 2023, growing at a CAGR of 9.92% during the forecast period from 2024 to 2030 to reach USD 2.43 billion by 2030. The cochlear implants market is observing substantial market growth primarily owing to the increasing prevalence of hearing loss & incurs substantial economic costs, investing in cochlear implants & improving access to these devices and supportive reimbursement policies are anticipated to further accelerate the overall growth of the cochlear implants market during the forecast period from 2024 to 2030.
Cochlear Implants Market Dynamics:
According to data from the World Health Organization (WHO) (2024), in 2050 about 2.5 billion are projected to experience some hearing loss, with at least 700 million individuals needing hearing rehabilitation globally. The above source further stated that more than 1 billion young adults are at risk of permanent and preventable hearing loss due to unsafe listening habits. To globally enhance ear and hearing care services, an additional annual investment of under USD 1.40 per person is required.
As per data from WHO (2024), in 2021, 136 million people were living with hearing loss in Africa, and by 2050, 337 million people would be affected by hearing problems in the African region. Additionally, according to the same source, in 2021, stated that 196 million people were affected by hearing loss in the European region. It also stated that by 2050, 236 million people would be affected by hearing problems in Europe.
Cochlear implants are essential in managing severe hearing loss, providing significant benefits for individuals. By directly stimulating the auditory nerve, these implants enable better sound perception, enhancing communication and quality of life. They help reduce the long-term costs associated with untreated hearing loss. Cochlear implants empower individuals, enabling them to lead more active and independent lives, thereby reducing the overall societal and economic costs associated with hearing impairment.
Favorable reimbursement policies and government initiatives are significantly enhancing access to cochlear implants. Globally, different countries have implemented similar measures. In the European Union, many nations provide subsidies or full coverage for cochlear implants through national health systems. For instance, the National Health Service in the UK covers cochlear implants for eligible patients, and similar programs exist across EU member states, aiming to improve accessibility.
Government and non-profit organizations also contribute significantly to making cochlear implants more accessible. Organizations such as the Cochlear Implant Foundation, provide funding assistance and advocate for policy changes to support individuals needing cochlear implants. These initiatives are vital in ensuring that advancements in hearing technology reach those who need them most, thereby improving the quality of life for individuals with hearing loss.
Therefore, the factors stated above collectively will drive the overall cochlear implant market growth.
However, post-surgical issues such as dizziness or vertigo and the availability of alternatives such as auditory brainstem implants and bone-anchored hearing systems, among others may prove to be challenging factors for the cochlear implant market growth.
Cochlear Implants Market Segment Analysis:
Cochlear implants market by Implantation (Unilateral Implantation and Bilateral Implantation), End-User (Adults and Paediatrics), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)
In the implantation segment of the cochlear implants market, the bilateral implantation category is expected to have a significant revenue share in the year 2023. This can be ascribed to various key features and advantages offered by these. Key features include improved sound localization, which helps users identify the direction of sounds, enhancing safety and spatial awareness in daily life. Bilateral implants also improve speech perception, particularly in noisy environments, by providing a more balanced auditory input, allowing for better speech recognition. Additionally, bilateral implantation can help preserve auditory nerve function by stimulating both sides of the auditory pathway, which is crucial for maintaining the brain's auditory processing capabilities.
The advantages of bilateral cochlear implants are especially pronounced in children, as they support the development of more natural speech, language, and listening skills. Early bilateral implantation in children is associated with better academic outcomes and social integration due to enhanced communication abilities. In adults, bilateral implants can significantly improve the overall quality of life, as they provide a fuller, more immersive sound experience, reducing the impact of hearing loss on everyday interactions
Therefore the various features and advantages of bilateral implantation enhance performance and usability, solidifying the significant impact on the growth of the overall cochlear implants market during the forecast period from 2024 to 2030.
North America is expected to dominate the overall cochlear implants market:
Among all the regions, North America is expected to dominate the cochlear implants market in the year 2023 and is expected to do the same during the forecast period from 2024 to 2030. This can be attributed to several factors, including the increasing prevalence of hearing loss, ongoing advancements in cochlear implant technology, regulatory approvals for new and innovative devices, and the rising demand for effective hearing restoration solutions, which are acting as key factors contributing to the growth of the cochlear implants market in the North America region.
As per data from WHO (2024), in 2021, 217 million people were living with hearing loss in the US. The same source further stated that by 2050, 322 million people would be affected by hearing problems in the US.
Cochlear implants provide an effective solution for individuals with severe to profound hearing impairment, offering a pathway to improved communication and quality of life. By bypassing damaged parts of the inner ear and directly stimulating the auditory nerve, cochlear implants help restore hearing. As the prevalence of hearing problems continues to rise, cochlear implants serve as an essential intervention to mitigate the personal and societal impacts of hearing impairment.
Rising product developmental activities by regulatory bodies in the region will further boost the market for cochlear implants. For example, In January 2022, Cochlear Limited announced that it secured approval from the US Food and Drug Administration (FDA) for its Cochlear Nucleus Implants to treat unilateral hearing loss (UHL) and single-sided deafness (SSD).
In addition to this, in June 2022, Envoy Medical. received approval for its investigational device exemption (IDE) application from the US Food and Drug Administration (FDA), allowing the company to conduct an early feasibility study of the Acclaim cochlear implant. The company conducted a single-center study of the new fully implanted cochlear implant in the US.
Therefore, the interplay of all the aforementioned factors would provide a conducive growth environment for the North American cochlear implant market.
Cochlear Implants Market key players:
Some of the key market players operating in the cochlear implants market include MED-EL Medical Electronics., Sonova., Oticon Medical, LLC, Cochlear Ltd., Envoy Medical., TODOC Co., Ltd., Advanced Bionics AG, ZHEJIANG NUROTRON, BIOTECHNOLOGY CO., LTD., Shanghai Listent Medical TECH Co., Ltd., Amplifon, and others.
Recent Developmental Activities in the Cochlear Implants Market:
Key Takeaways from the Cochlear Implants Market Report Study
Target Audience who can be benefited from this Cochlear Implants Market Report Study
Frequently Asked Questions for the Cochlear Implants Market:
Cochlear implant is a small electronic device that electrically stimulates the cochlear nerve. The implant has external and internal parts. The external part sits behind the ear and picks up sounds with a microphone. It then processes the sound and transmits it to the internal part of the implant.
The cochlear implants market was valued at USD 1.38 billion in 2023, growing at a CAGR of 9.92% during the forecast period from 2024 to 2030 to reach USD 2.43 billion by 2030.
The cochlear implants market is observing substantial market growth primarily owing to the increasing prevalence of hearing loss & incurs substantial economic costs, investing in cochlear implants & improving access to these devices and, supportive reimbursement policies are anticipated to further accelerate the overall growth of the cochlear implants market during the forecast period from 2024 to 2030.
Some of the key market players operating in cochlear implants include MED-EL Medical Electronics., Sonova., Oticon Medical, LLC, Cochlear Ltd., Envoy Medical., TODOC Co., Ltd., Advanced Bionics AG, ZHEJIANG NUROTRON, BIOTECHNOLOGY CO., LTD., Shanghai Listent Medical TECH Co., Ltd., Amplifon, and others.
North America is expected to dominate the overall Cochlear Implants market during the forecast period from 2024 to 2030. This can be attributed to several factors, including the increasing prevalence of hearing loss, ongoing advancements in cochlear implant technology, regulatory approvals for new and innovative devices, and the rising demand for effective hearing restoration solutions, which are acting as key factors contributing to the growth of the cochlear implants market in the North America region.